Home
/ ACell
/ Competitors

ACell Competitors and Similar CompaniesClear all

ACell's competitors and similar companies include Osiris Therapeutics, Xtant Medical, Acelity and Organogenesis.

	ACell ACell is a company focused on the development and commercialization of medical devices for wound management and surgical soft tissue repair.	Osiris Therapeutics Osiris Therapeutics is a company that researches, develops, manufactures, markets, and distributes regenerative medicine products.	Xtant Medical Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.	Acelity Acelity is a medical device company offering wound therapeutics products.	Organogenesis Organogenesis is a leader in regenerative medicine, specializing in bio-active wound healing and oral regeneration.
Founding Date	Founding Date 2002	Founding Date 1992	Founding Date 2006	Founding Date 1976	Founding Date 1985
Type	Type Public	Type Subsidiary	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare biotech genetics	Tags Healthcare Manufacturing & Industrial medical devices surgical solutions	Tags Healthcare medical devices therapy	Tags Healthcare biotech drug development life sciences
Locations	Locations Columbia, US HQ Lafayette, US	Locations Columbia, US HQ	Locations Belgrade, US HQ Miamisburg, US	Locations San Antonio, US HQ Lane Cove West, AU Wien, AT Wien, AT Mississauga, CA see more	Locations Canton, US HQ Kanton Reinach, CH Canton, US San Diego, US
Employees	Employees 400	Employees 1561% decrease	Employees 14115% decrease	Employees 2,106	Employees 9791% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 77.1 m	Valuation ($) N/A	Valuation ($) 395.1 m
Financial
Revenue (est.)	Revenue (est.) $100.8m (FY, 2019)	Revenue (est.) $142.8m (FY, 2018)	Revenue (est.) $133.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $564.2m (FY, 2025)
Cost of goods	Cost of goods $19.1m (FY, 2019)	Cost of goods $38.1m (FY, 2018)	Cost of goods $49.7m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $81.7m (FY, 2019)	Gross profit $104.7m (FY, 2018)	Gross profit $84.3m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income $1.4m (FY, 2019)	Net income $36.9m (FY, 2018)	Net income $5m (FY, 2025)	Net income N/A	Net income $37m (FY, 2025)
Funding
Total funding raised	Total funding raised $ 8.7m	Total funding raised $ 65m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 75m